CNSP

About CNS Pharmaceuticals, Inc. Common Stock (CNSP) Stock

CNS Pharmaceuticals, Inc. Common Stock (CNSP) closed the 2026-09-17 session at $5.12, down 6.91% versus the previous close (-0.38). The stock opened at $5.35 and traded between $5.05 and $5.35 during that session. Session trading volume was 3K shares. The volume-weighted average price (VWAP) is $5.24.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

CNS Pharmaceuticals, Inc. Common Stock has a market capitalization of $8.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CNSP is listed on the XNAS exchange. The company employs approximately 8 people. CNS Pharmaceuticals, Inc. Common Stock is headquartered in HOUSTON, TX. The recorded listing date is 2019-11-08.

On this page you can find market CNSP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.